Adherence to therapy provided free of charge tends to be greater for tacrolimus than for ciclosporin among renal transplant recipients

Source: Inpharma, Volume 1, Number 1484, 2005-04-23 , pp. 19-19(1)

Publisher: Adis International

Buy & download fulltext article:

OR

Price: $37.95 plus tax (Refund Policy)

Keywords: Ciclosporin, therapeutic use; Health-economics; Renal-transplant-rejection, prevention; Tacrolimus, therapeutic use

Document Type: Research article

Publication date: 2005-01-01

Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page